4
Changes in Ownership
Candel Therapeutics, Inc. Filed Acc 0002139479-26-000004
Options or other derivatives
- Chief Commercial Officer acquired 285,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Sims Mark E. · Chief Commercial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-07-06 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +285,000 | 285,000 | D |
Loading xslF345X06/ownership.xml…